Despite being a relatively straightforward clinical diagnosis, recognition of hidradenitis suppurativa (HS) is highly variable, and clinical management is challenging and complex. Written by the world’s leading experts in HS, A Comprehensive Guide to Hidradenitis Suppurativa brings together up-to-date scientific evidence on the diagnosis, patho-mechanisms, comorbidities, and multi-faceted medical and surgical interventions for this debilitating condition—in one convenient reference.
Key Features
-
Covers every aspect of this complex skin disorder: etiology, pathophysiology, epidemiology, medical, alternative therapies, a range of surgical options, laser treatments, and comorbidities.
-
Discusses specific patient populations such as children, women of childbearing potential, and pregnant and breastfeeding women. Because HS has higher prevalence in people of skin of color, this patient population is well-documented in the text.
-
Offers insights into multi-disciplinary care, patient support and education, patients at risk for rapid disease progression, and clinical and translational research.
-
Features procedural videos covering laser therapies, de-roofing procedures, excisions and closure techniques, cryoinsufflation techniques, and special wound care material selection and techniques.
-
Includes recent FDA-approved drugs as well as those drugs and therapies that show future promise.
-
Identifies evidence gaps that provide a springboard to the future innovations in HS care to come.
-
Edited and authored by global experts who have co-authored 2019 U.S. and Canadian guidelines on hidradenitis suppurativa.
Author Information
By Vivian Y. Shi, MD, Associate Professor, Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; Jennifer L. Hsiao, MD, Assistant Clinical Professor of Dermatology, Director, Hidradenitis Suppurativa Specialty Clinic, University of California, Los Angeles, California, USA; Michelle A. Lowes, MD, PhD, Associate Professor of Clinical Investigation, The Laboratory for Investigative Dermatology, Rockefeller University, New York, New York; Iltefat H. Hamzavi, MD, Henry Ford Hospital, Clinical Associate Professor, Department of Dermatology, Wayne State University SOM and President, HS Foundation, Detroit, Michigan
Foreword
1 Historic Perspectives
2 Epidemiology
3 Clinical Manifestations and Phenotypes
4 Differential Diagnosis
5 Histopathology
6 Imaging Modalities
7 Clinical Evaluation
8 Comorbidities and Systemic Associations
9 Disease Complications
10 Follicular Occlusion and Inflammation
11 Microbiome
12 Genetics and Epigenetics
13 Disease Evaluation & Outcome Measures
14 Overview and Comparison of Management Guidelines
15 Topical Therapeutics
16 Systemic Antibiotics
17 Non-Antibiotic Systemic Therapeutics for HS
18 Targeted Therapeutics: Biologics, Small Molecules
19 Pain and Itch Control
20 Wound Care
21 Quality of Life
22 Office-Based Non-Excision Procedures
23 Surgical Excisions for Hidradenitis Suppurativa
24 Office-based excision for hidradenitis suppurativa: a surgeon's decades-long experience
25 Laser and Light-Based Treatments
26 Other Procedural Treatments
27 Lifestyle Modifications
28 Complementary and Alternative Medicine (CAM)
29 Pediatrics
30 Skin of Color
31 Hidradenitis Suppurativa in Women
32 HS Action Plan
32 HS Multi-Disciplinary Approach
33 HS Support Groups
34 Pipeline Therapeutics
35 The Future
"Hidradenitis suppurativa (HS) is an extremely distressing dermatologic disorder. It is also difficult to treat. Often the diagnosis is not made until many years have passed, and all the while, patients suffer, developing painful abscesses, sinus tracts draining pus, and scarring. This reference book is completely devoted to hidradenitis suppurativa risk factors (genetics, lifestyle, sex, body mass index, etc.) to inform an earlier diagnosis so treatment can be instituted sooner, thus being proactive in reducing chronicity and complications of the disease." ©Doody’s Review Service, 2023, Patricia Wong, MD (Private Practice) Doody's Score: 4 stars!
